Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9237fdf6dca9ac365fc5166858e7862 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6e64477714c8586c8931c6360f33a37c http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9a89433fb6e8a3597a7ede8207324e68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee91287a4e43faaddc49eecca7019b4a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b866ebcd3ac0f1276f500dd188bba168 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-001 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J71-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J19-00 |
filingDate |
2011-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01f919247634cfe5c395d4f60d6baf98 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cfc929de98e379b85ed65895dcc3709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f23fb51410c50696b17139b8d99422e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8fddf4920ad753df333e0dc5f59048f |
publicationDate |
2011-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2011134954-A1 |
titleOfInvention |
Anticancer steroidal lactones unsaturated in position 7 (8) |
abstract |
A compound of general formula (I ), wherein R 1 -R 17 and the ------ line take various meanings for use in the treatment of cancer. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9487554-B2 |
priorityDate |
2010-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |